2021
DOI: 10.1016/j.immuni.2020.11.007
|View full text |Cite
|
Sign up to set email alerts
|

A Binary Cre Transgenic Approach Dissects Microglia and CNS Border-Associated Macrophages

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

7
107
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 127 publications
(121 citation statements)
references
References 80 publications
7
107
0
Order By: Relevance
“…5C and Supplementary Fig. 5A-B) 25, 31, 32 . Unlike pro-inflammatory reactive astrocytes during brain injury 33 , EGCs were activated early after muscularis inflammation and produced increased amounts of factors that are able to promote the differentiation of alternatively activated Mφs, such as Lif, Serpine-1, Gdf15, Gdnf, Cxcl10 and Csf1 (Fig.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…5C and Supplementary Fig. 5A-B) 25, 31, 32 . Unlike pro-inflammatory reactive astrocytes during brain injury 33 , EGCs were activated early after muscularis inflammation and produced increased amounts of factors that are able to promote the differentiation of alternatively activated Mφs, such as Lif, Serpine-1, Gdf15, Gdnf, Cxcl10 and Csf1 (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…The whole small intestine of each mouse was peeled by removing the mucosa and submucosa and samples were flash-frozen in liquid nitrogen and stored at −80°C until further processing. Samples were immunoprecipitated at the Weizman Instiute (Israel) according to the published protocol 6, 7 . In brief, samples were homogenized in 4 mL cold homogenization buffer (50 mM Tris, pH 7.4, 100 mM KCl, 12 mM MgCl2, 1% NP-40, 1 mM DTT, 1:100 protease inhibitor (Sigma-Aldrich), 200 U/mL RNasin (Promega) and 0.1 mg/mL cycloheximide (Sigma-Aldrich)) with a Dounce homogenizer (Sigma-Aldrich) until the suspension was homogeneous.…”
Section: Supplementary Informationmentioning
confidence: 99%
See 1 more Smart Citation
“…The homeostatic receptor P2RY12 can also be used to efficiently target microglia [90]. Even still, Sall1-CreER targets microglia and a subset of epiplexus CP BAMs [7,171], whereas Cx3cr1-CreER and P2ry12-CreER target both microglia and nearly all types of BAM cells to some extent [90,198,210]. It is important to note that the expression of these homeostatic markers diminishes during disease progression, and particular attention should be exercised as to the timing of gene deletion or manipulation.…”
Section: Genetic Models To Target Microgliamentioning
confidence: 99%
“…Some studies using scRNA-seq have already analyzed these cells separately [71], through dissection of leptomeninges, the perivascular space and parenchyma, and the choroid plexus; however, experimental manipulation of microglia and other CAMs/BAMs independently remains a challenge. Fortunately, Kim et al [146] have just developed a binary transgenic system involving complementation-competent NCre and CCre fragments. Their expression is driven by two distinct promoters: Sall1 ncre :Cx3cr1 ccre , which specifically targets parenchymal microglia, and Lyve1 ncre : Cx3cr1 ccre , which allows the ability to target various CAMs throughout the brain.…”
Section: In Vivo Modelsmentioning
confidence: 99%